The Converge IDE Trial

HealthMedicineAtrial Fibrillation
Written By Armin Kiankhooy
 

Hybrid Ablation is gaining steam! The Converge IDE trial proves the advantage of the Hybrid Approach to stand-alone catheter ablation in difficult to treat persistent and long-standing persistent atrial fibrillation patients.

 
Armin Kiankhooy
Previous

Alcohol and Atrial Fibrillation
Next

The Patient Experience with Atrial Fibrillation & StopAFib.org